1. Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review

   • Edith A. Perez
   • Chau Dang
   • Javier Cortes

   Review 19 May 2022 Pages: 1 - 11

   

2. Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis

   • Alexandra Giatromanolaki
   • Anastasia G. Gkegka
   • Michael Koukourakis

   Preclinical study 28 April 2022 Pages: 13 - 23

   

3. Characterizing experiences of non-medical switching to trastuzumab biosimilars using data from internet-based surveys with US-based oncologists and breast cancer patients

   • Elizabeth Lerner Papautsky
   • Martha Carlson
   • Maryam B. Lustberg

   Preclinical study Open access 14 May 2022 Pages: 25 - 33

   

4. Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancer

   • Julia E. McGuinness
   • Vicky Ro
   • Katherine D. Crew

   Preclinical study 16 May 2022 Pages: 35 - 47

   

5. Women with short survival after diagnosis of metastatic breast cancer: a population-based registry study

   • Caroline Boman
   • Luisa Edman Kessler
   • Theodoros Foukakis

   Clinical trial Open access 24 April 2022 Pages: 49 - 56

   

6. Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer

   • Mario E. Lacouture
   • Shari B. Goldfarb
   • Julie E. Lang

   Clinical trial Open access 26 April 2022 Pages: 57 - 64

   

7. The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers

   • Karen S. Anderson
   • Timothy K. Erick
   • Beth Overmoyer

   Clinical trial 28 April 2022 Pages: 65 - 78

   

8. Association of breast cancer risk, density, and stiffness: global tissue stiffness on breast MR elastography (MRE)

   • Bhavika K. Patel
   • Kay Pepin
   • Richard Ehman

   Clinical trial 30 April 2022 Pages: 79 - 89

   

9. Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study

   • Doris M. Howell
   • Kelly Metcalfe
   • May Lynne Quan

   Epidemiology 24 April 2022 Pages: 91 - 102

10. Effect of estradiol as a continuous variable on breast cancer survival by menopausal status: a cohort study in China

    • Junxian Li
    • Chenyang Li
    • Kexin Chen

    Epidemiology 25 April 2022 Pages: 103 - 111

    

11. Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy

    • Brenna C. McDonald
    • Kathleen Van Dyk
    • Andrew J. Saykin

    Epidemiology 27 April 2022 Pages: 113 - 126

    

12. Hypertensive diseases of pregnancy and risk of breast cancer in the Black Women’s Health Study

    • Zahna Bigham
    • Yvonne Robles
    • Kimberly A. Bertrand

    Epidemiology 28 April 2022 Pages: 127 - 135

13. Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ

    • Melissa Anne Mallory
    • Karissa Whiting
    • Melissa L. Pilewskie

    Epidemiology 29 April 2022 Pages: 137 - 148

    

14. Serum hormone levels and normal breast histology among premenopausal women

    • Mark E. Sherman
    • Thomas de Bel
    • Jeroen van der Laak

    Epidemiology 03 May 2022 Pages: 149 - 158

    

15. Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study

    • Mark van Barele
    • Amy Rieborn
    • Maartje J. Hooning

    Epidemiology Open access 04 May 2022 Pages: 159 - 170

    

16. Patient perspectives on window of opportunity clinical trials in early-stage breast cancer

    • Divya A. Parikh
    • Lisa Kody
    • Jennifer L. Caswell-Jin

    Epidemiology 11 May 2022 Pages: 171 - 178

    

17. CBCRisk-Black: a personalized contralateral breast cancer risk prediction model for black women

    • Ibrahim Hossain Sajal
    • Marzana Chowdhury
    • Swati Biswas

    Epidemiology 13 May 2022 Pages: 179 - 186

    

18. Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region

    • Siham Chafai Elalaoui
    • Fatima Zohra Laarabi
    • Abdelaziz sefiani

    Epidemiology 17 May 2022 Pages: 187 - 198

19. Axillary radiation alone is a suboptimal treatment for ypN + in patients with triple negative breast cancer and axillary lymph node dissection should be considered in this setting

    • Parinita Keshav Swarnkar
    • Kefah Mokbel

    Letter to the Editor 03 May 2022 Pages: 199 - 199